vogelstein b@amikacin@evidence@thirumoorthi mc@subject@rapid@j clin pharmacol@kearns gl@aminoglycoside@kidney@macdonald ne@defect@appeared@extremely@am rev respir dis@autret e@jan@kelly hw@plan@greater@aa@schofield dh@chest@individual@patients@profile@hewitt wl@intriguing@kanamycin@am j med us amikacin symp@j pediatr@clin pharmacol ther@rubio tt@secretion@leeder js@eur j pediatr@fibrosis@aminoglycosides@j clin hosp pharm@finkelstein-e@clearances@isles a@fraser gl@yaffe sj@develop pharm ther@child@primary@int j clin pharmacol res@pedersen ss@horrevorts@prove@michalsen h@utilizing@extended@jusko wj@antimicrob agents chemother@total@eur j clin pharmacol@levy j@goldfarb j@rate@padoan r@hall-k@gentamicin@clearance@pharmacokinetic@cystic-fibrosis@human@elimination@courcol rj@j infect dis@letter]@kraemer r@drugs@therapy@observation@j antimicrob chemother@monitor@nahata mc@possible@drug intel clin pharm@noted@renal@j-pediatr@patient's@martini n@pediatrics@am j med@clarke jt@spino m@significantly@cystic@normally@